(Q39359785)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Ying Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Li Shi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Chun Han

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yishang Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Junlan Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Cheng Cao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

14 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1403-1410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-012-0388-1

29 January 2020

exact match

0 references

cites work

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

A novel interaction between HER2/neu and cyclin E in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

HER-2 positive and p53 negative breast cancers are associated with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Trastuzumab: triumphs and tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

IQGAP1 protein binds human epidermal growth factor receptor 2 (HER2) and modulates trastuzumab resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Role of melatonin in the epigenetic regulation of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

The expression and clinical significance of GTP-binding RAS-like 3 (ARHI) and microRNA 221 and 222 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Differential sensitivities of trastuzumab (Herceptin)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0388-1

Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity

21 January 2018

1 reference

12 December 2020

Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.

1 reference

12 December 2020

Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway

1 reference

12 December 2020

Cetuximab in non-small-cell lung cancer

1 reference

12 December 2020

Headway in resistance to endocrine therapy in breast cancer

1 reference

12 December 2020

Advances on EGFR mutation for lung cancer

1 reference

12 December 2020

Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action

1 reference

12 December 2020

Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium

1 reference

12 December 2020

Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival

1 reference

12 December 2020

Biochemistry and Biology of ARHI (DIRAS3), an Imprinted Tumor Suppressor Gene Whose Expression Is Lost in Ovarian and Breast Cancers

1 reference

12 December 2020

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

1 reference

12 December 2020

Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest

1 reference

12 December 2020

Molecular oncogenesis of prostate adenocarcinoma: role of the human epidermal growth factor receptor 2 (HER-2/neu).

1 reference

12 December 2020

The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells

1 reference

12 December 2020

Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells

1 reference

12 December 2020

The role of survivin in diagnosis, prognosis and treatment of breast cancer

1 reference

12 December 2020

ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers

1 reference

12 December 2020

10.1007/S13277-012-0388-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22528939%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference